StonvexLoading…
StonvexStonvexStonvexCore line items from NOMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €3.03B | €3.10B | €3.04B | €2.94B |
Operating Income | €325.40M | €387.00M | €340.40M | €375.40M |
Net Income | €136.70M | €227.10M | €192.70M | €249.80M |
EPS (Diluted) | €0.91 | €1.40 | €1.13 | €1.43 |
Total Assets | €6.33B | €6.43B | €6.42B | €6.33B |
Total Liabilities | €3.84B | €3.77B | €3.82B | €3.72B |
Cash & Equivalents | Not available | Not available | Not available | €369.40M |
Free Cash Flow OCF − CapEx | €252.20M | €355.10M | €348.40M | €224.70M |
Shares Outstanding | Not available | Not available | Not available | Not available |